Skip to main content
. 2019 Aug 13;9:754. doi: 10.3389/fonc.2019.00754

Figure 1.

Figure 1

SIRT5 expression is increased in ovarian cancer tissues and high SIRT5 level predicts poor chemo-response. (A) The mRNA expression of Sirtuins in patients with ovarian cancer (GEPIA). (B) Immunohistochemical staining results of SIRT5 expression in 90 cases ovarian cancer tissues and 10 cases normal tissues microarrays. (C) Representative immunohistochemical staining images of SIRT5 expression (positive or negative) in ovarian cancer and normal tissues. (Magnification, × 400; Scale bar = 20 μm). (D) High SIRT5 level predicts poor progression-free survival (PFS) by online Kaplan-Meier analysis. **P < 0.01.